| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 10 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Product containing glucose and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| dekstrose 5 g/100 ml (5 %) injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 25 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| natriumklorid 0,9 %/glucose 5 % infusionsvæske opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) infusionsvæske opløsning, hætteglas a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| dekstrosepræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 25 % injektionsvæske til spædbørn, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| kaliumchlorid 13,5 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Ringer-laktat, opløsning med 2,5 % glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Glucose 500 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| natriumchlorid 0,45 % + glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 40 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 60 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 20 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| kaliumchlorid 10 mmol/glucose 5 %/natriumchlorid 0,45 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 70 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| kaliumchlorid 10 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| penicillin G + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) injektionsvæske opløsning, hætteglas a 1000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 5 % i 0,2 % normalt saltvand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| theophyllin + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Ringer-laktat, opløsning + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| natriumchlorid 0,225 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| kalium + glucose/saltvand infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| kalium + glucose infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) injektionsvæske, opløsning, flaske a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 60 % i vand, infusionsvæske, opløsning, pose a 1000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Product containing glucose and potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| glucose 60 % i vand, infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 5 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| natriumchlorid 0,45 %/glucose 2,5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 10 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Continuous infusion of dextrose saline |
Direct substance |
False |
Glucose |
Inferred relationship |
Some |
1 |
| milrinonlaktat 200 µg/ml (5 %) injektionsvæske, opløsning, pose a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Glucose-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| kombinationspræparat med natriumlactat, infusionsvæske, opløsning, polyethylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Product containing glucose in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| natriumlactat Komb., infusionsvæske, opløsning i polyethylenflaske a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Continuous infusion of dextrose saline |
Direct substance |
False |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing glucose and glutathione and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| 240 minute plasma glucose measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Continuous infusion of dextrose saline |
Direct substance |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid with sensor placement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
4 |
| 300 minute plasma glucose measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
3 |
| Measurement of glucose 4 hours after glucose challenge for glucose tolerance test |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Measurement of glucose 1 hour after glucose challenge for glucose tolerance test |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Measurement of fasting glucose in urine specimen using dipstick |
Component |
False |
Glucose |
Inferred relationship |
Some |
|
| Urine screening for glucose |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass concentration of glucose in first peritoneal dialysis fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose measurement by monitoring device (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass concentration of glucose in predialysis peritoneal dialysis fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of substance rate of glucose excretion in urine specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| beregning af estimeret gennemsnitligt glucose baseret på hæmoglobin A1c |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| glucometertest udført på sengeafdeling |
Component |
False |
Glucose |
Inferred relationship |
Some |
1 |
| Measurement of urea, sodium, potassium, chloride, bicarbonate and glucose (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
4 |
| Quantitative measurement of mass concentration of glucose in pericardial fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass rate of excretion of glucose in 24 hour urine specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass concentration of glucose in peritoneal dialysis fluid specimen at 4 hours postperitoneal dialysis (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass concentration of glucose in serum or plasma specimen 6 hours after glucose challenge (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass concentration of glucose in postcalorie fasting serum or plasma specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass concentration of glucose in synovial fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass concentration of glucose in peritoneal dialysis fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass concentration of glucose in 1 hour postprandial urine specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass concentration of glucose in serum or plasma specimen 120 minutes after 75 gram oral glucose challenge (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Quantitative measurement of mass concentration of glucose in pleural fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
| tetracainhydrochlorid 0,2 %/glucose 6% injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| tetracainhydrochlorid 0,3 %/glucose 6 % injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| dextrose 7,5 % wt/wt/lidocainhydrochlorid 1,5 % wt/wt injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Glucose tolerance test, antenatal (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Measurement of fasting glucose in urine specimen using dipstick |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Urine dipstick for glucose |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Protein-bound glucose (substance) |
Is a |
False |
Glucose |
Inferred relationship |
Some |
|
| Product containing glucose and sodium chloride in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose monohydrate (substance) |
Is a |
False |
Glucose |
Inferred relationship |
Some |
|
| Dextrose 60% in water conventional release solution for infusion 1000mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Dextrose 60% in water conventional release solution for infusion 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
| Protein-bound glucose (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Glucose |
Inferred relationship |
Some |
|
| Glucose monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Glucose |
Inferred relationship |
Some |
|
| Anhydrous glucose |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Glucose |
Inferred relationship |
Some |
|
| Glucose- and potassium chloride-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing glucose and potassium chloride and sodium chloride in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Product containing only bupivacaine and glucose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
2 |
| Caffeine and glucose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing only glucose and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Product containing only glucose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose and glutathione and hypromellose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
3 |
| Product containing only glucose and molasses (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
| Glucose and potassium chloride only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
| Glucose and potassium chloride and sodium chloride only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
FHIR